The role of EIF4G2 in CRC is not well studied, although it is reported to control the G1 phase inhibitor p27Kip1 to alter proliferation in glioblastoma, human embryonic kidney and AML cells [46,55]. Here, CDKN1B is linked to acute myeloid leukemia.